Biochimica et Biophysica Acta 1998-09-16

Flavin-containing monooxygenase mediated metabolism of benzydamine in perfused brain and liver.

A Kawaji, M Isobe, Y Tochino, E Takabatake, Y Chikaoka, Y Nomura, M Tamura

Index: Biochim. Biophys. Acta 1425(1) , 41-6, (1998)

Full Text: HTML

Abstract

Benzydamine (BZY) N-oxidation mediated by flavin-containing monooxygenase (FMO) was evaluated in perfused brain and liver. Following 20 min of perfusion with modified Ringer solution, the infusion of BZY into brain or liver led to production of BZY N-oxide. BZY N-oxide, a metabolite of BZY oxidized exclusively by FMO, was mostly recovered in the effluent without undergoing further metabolism or reduction back to the parent substrate. The BZY N-oxide formation rate increased as the infusion concentration of BZY increased both in perfused brain and perfused liver. BZY N-oxidation activities in perfused rat brain and liver were 4.2 nmol/g brain/min and 50 nmol/g liver/min, respectively, although the BZY N-oxidation activity in brain homogenates was one 4000th that in liver homogenates. This is the first study of FMO activity in brain in situ.


Related Compounds

Related Articles:

HPLC determination of benzydamine and its metabolite N-oxide in plasma following oral administration or topical application in man, using fluorimetric detection.

1986-04-01

[Pharmacol. Res. Commun. 18(4) , 385-403, (1986)]

Determination of benzydamine and its N-oxide in biological fluids by high-performance liquid chromatography.

[J. Chromatogr. A. 529(1) , 113-23, (1990)]

Biotransformation of benzydamine by microsomes and precision-cut slices prepared from cattle liver.

2002-01-01

[Xenobiotica 32(1) , 73-86, (2002)]

Can caffeine metabolism be used as an in-vivo probe for human flavin-containing monooxygenase activity?

2000-04-01

[Pharmacogenetics 10(3) , 275-7, (2000)]

More Articles...